AIM: To investigate the association of accelerometry daily step count with 3-year overall survival (OS) in patients with malignant pleural effusion (MPE). METHODS: This is a pooled analysis of four studies in patients with MPE. Activity behaviour was captured using 7-day accelerometry (Actigraph GT3X+) and survival information was collected from medical records. Participants were divided in two groups based on median number of steps: high (n=81, median of 7509 [interquartile range (IQR): 5699; 9844] steps) and low steps (n=82, 2940 [IQR: 1676; 3947] steps). Data were analysed with Cox regression analyses (hazard ratio [HR] and 95% confidence intervals [95% CI]) and Kaplan-Meier method to explore the association of daily step count with 3-year OS. RESULTS: A total of 163 MPE patients had 57 and 72 deaths recorded in the high and low steps group, respectively. An unadjusted HR of 0.50 (95% CI: 0.35-0.71) was observed for those in the high steps group. High steps group presented a median 3-year OS of 18.9 (95% CI: 13.4-24.3) months vs. 9.3 (95% CI: 6.2-12.4) months in low steps (p<0.001). An adjusted HR of 0.48 (95% CI: 0.31-0.74) was observed for patients presenting with high number of steps after controlling for age, cancer type, serum albumin, Eastern Cooperative Oncology Group performance status (0, 1, 2, and 3) and sedentary time. CONCLUSION: This exploratory study indicates accelerometry-based physical activity measurement is a meaningful prognostic marker in patients with MPE, even after controlling for established prognostic factors. Accelerometry may add value to existing prognostic models.
This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
Clinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Shape-sensing robotic-assisted bronchoscopy achieved a strict diagnostic yield of 70.2% with a low pneumothorax rate of 3.3%, demonstrating that earlier tissue diagnosis of very small pulmonary nodules is feasible and safe for clinical practice.
Up nextJournal of Thoracic DiseaseOct 30, 2026Read
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
Active infection is not an absolute contraindication to endobronchial valve placement, but positive pressure ventilation significantly increases clinical failure odds with an aOR of 3.00 at P < 0.001.